In response to “Selective serotonin reuptake inhibitors—A new modality for the treatment of lymphoma/leukaemia?” by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424–1435]

John Gordon; Nicholas Barnes; Elisabeth Meredith; Mark Drayson

doi:10.1016/J.BCP.2008.02.009

In response to “Selective serotonin reuptake inhibitors—A new modality for the treatment of lymphoma/leukaemia?” by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424–1435]

John Gordon
, Nicholas Barnes
, Elisabeth Meredith
, Mark Drayson

Research output: Contribution to journal › Article

2 Citations (Scopus)

Original language	English
Pages (from-to)	e1-e3
Journal	Biochemical Pharmacology
Volume	75
Issue number	6
DOIs	https://doi.org/10.1016/J.BCP.2008.02.009
Publication status	Published - 15 Mar 2008

Access to Document

10.1016/J.BCP.2008.02.009

Cite this

@article{04842bffb4924a6cb5f387152228df65,

title = "In response to “Selective serotonin reuptake inhibitors—A new modality for the treatment of lymphoma/leukaemia?” by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424–1435]",

author = "John Gordon and Nicholas Barnes and Elisabeth Meredith and Mark Drayson",

year = "2008",

month = mar,

day = "15",

doi = "10.1016/J.BCP.2008.02.009",

language = "English",

volume = "75",

pages = "e1--e3",

journal = "Biochemical Pharmacology",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - In response to “Selective serotonin reuptake inhibitors—A new modality for the treatment of lymphoma/leukaemia?” by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424–1435]

AU - Gordon, John

AU - Barnes, Nicholas

AU - Meredith, Elisabeth

AU - Drayson, Mark

PY - 2008/3/15

Y1 - 2008/3/15

U2 - 10.1016/J.BCP.2008.02.009

DO - 10.1016/J.BCP.2008.02.009

M3 - Article

C2 - 18319082

VL - 75

SP - e1-e3

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

IS - 6

ER -